Elite Pharmaceuticals ELTP
OTC ELTP
$0.25 +0.01 (+4.17%)
At close: Oct 21, 2026 · 4:00 PM EDT

Elite Pharmaceuticals (ELTP) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Elite Pharmaceuticals' Depreciation & Amortization (CF) came in at $252,975 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 8.1% from $275,413 a year earlier but up 0.4% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Elite Pharmaceuticals reported Depreciation & Amortization (CF) of $1.05 million, down 5.2% year-over-year; for FY2026 (ended Mar 31, 2026), it was $1.07 million, down 12.6% from FY2025.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of -4.0% (FY2021 to FY2026).
  • Going back by fiscal year, Depreciation & Amortization (CF) was $1.23 million in FY2025 (-7.1%), $1.32 million in FY2024 (+3.4%), $1.28 million in FY2023 (+5.7%) and $1.21 million in FY2022 (-8.0%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $227,356 (fiscal Q2 2025) to $344,091 (fiscal Q4 2023).
  • Year-over-year, Depreciation & Amortization (CF) has declined for three consecutive quarters, with an average decline of 9.7% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in fiscal Q2 2026 (growth of 21.1%), and the weakest in fiscal Q2 2025 (a decline of 30.5%).
  • Business Quant data shows ELTP's Depreciation & Amortization (CF) at $252,077 (Q4 2026), $268,662 (Q3 2026) and $275,391 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.12 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 194.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.93 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 98.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.62 Bn
10 Elite Pharmaceuticals 269.31 Mn 150.98 Mn 13.51 Mn 252,975.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 252,975.00
Mar 31, 2026 252,077.00
Dec 31, 2025 268,662.00
Sep 30, 2025 275,391.00
Jun 30, 2025 275,413.00
Mar 31, 2025 290,392.00
Dec 31, 2024 313,060.00
Sep 30, 2024 227,356.00
Jun 30, 2024 322,103.00
Mar 31, 2024 328,382.00
Dec 31, 2023 336,614.00
Sep 30, 2023 327,240.00
Jun 30, 2023 328,282.00
Mar 31, 2023 344,091.00
Dec 31, 2022 317,685.00
Sep 30, 2022 319,552.00
Jun 30, 2022 296,294.00
Mar 31, 2022 300,822.00
Dec 31, 2021 296,559.00
Sep 30, 2021 299,036.00
API Access

Elite Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ELTP&period=max&api_key=YOUR_API_KEY